FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155873662> ?p ?o ?g. }

• W2155873662 endingPage "402" @default.
• W2155873662 startingPage "394" @default.
• W2155873662 abstract "OBJECTIVE To evaluate the efficacy and safety of empagliflozin/linagliptin in subjects with type 2 diabetes. RESEARCH DESIGN AND METHODS Subjects not receiving antidiabetes therapy for ≥12 weeks were randomized to empagliflozin 25 mg/linagliptin 5 mg (n = 137), empagliflozin 10 mg/linagliptin 5 mg (n = 136), empagliflozin 25 mg (n = 135), empagliflozin 10 mg (n = 134), or linagliptin 5 mg (n = 135) for 52 weeks. The primary end point was change from baseline in HbA1c at week 24. RESULTS Mean HbA1c at baseline was 7.99–8.05% (64 mmol/mol). At week 24, adjusted mean (SE) changes from baseline in HbA1c with empagliflozin 25 mg/linagliptin 5 mg, empagliflozin 10 mg/linagliptin 5 mg, empagliflozin 25 mg, empagliflozin 10 mg, and linagliptin 5 mg were −1.08 (0.06)% (−11.8 [0.7] mmol/mol), −1.24 (0.06)% (−13.6 [0.7] mmol/mol), −0.95 (0.06)% (−10.4 [0.7] mmol/mol), −0.83 (0.06)% (−9.1 [0.7] mmol/mol), and −0.67 (0.06)% (−7.3 [0.7] mmol/mol), respectively. Reductions in HbA1c were significantly greater for empagliflozin 25 mg/linagliptin 5 mg compared with linagliptin 5 mg (P &lt; 0.001) but not compared with empagliflozin 25 mg and were significantly greater for empagliflozin 10 mg/linagliptin 5 mg compared with the individual components (P &lt; 0.001 for both). At week 24, 55.4%, 62.3%, 41.5%, 38.8%, and 32.3% of subjects with baseline HbA1c ≥7% (≥53 mmol/mol) reached HbA1c &lt;7% with empagliflozin 25 mg/linagliptin 5 mg, empagliflozin 10 mg/linagliptin 5 mg, empagliflozin 25 mg, empagliflozin 10 mg, and linagliptin 5 mg, respectively. Efficacy was maintained at week 52. The proportion of subjects with adverse events (AEs) over 52 weeks was similar across groups (68.9–81.5%), with no confirmed hypoglycemic AEs. CONCLUSIONS Reductions from baseline in HbA1c with empagliflozin/linagliptin were significantly different versus linagliptin and empagliflozin 10 mg but not versus empagliflozin 25 mg. Empagliflozin/linagliptin was well tolerated." @default.
• W2155873662 created "2016-06-24" @default.
• W2155873662 creator A5000118493 @default.
• W2155873662 creator A5012223927 @default.
• W2155873662 creator A5039965133 @default.
• W2155873662 creator A5043462775 @default.
• W2155873662 creator A5072715177 @default.
• W2155873662 creator A5073917506 @default.
• W2155873662 creator A5085478829 @default.
• W2155873662 date "2015-01-29" @default.
• W2155873662 modified "2023-10-10" @default.
• W2155873662 title "Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes" @default.
• W2155873662 cites W1762835157 @default.
• W2155873662 cites W1982712467 @default.
• W2155873662 cites W1990025047 @default.
• W2155873662 cites W2011238752 @default.
• W2155873662 cites W2022248805 @default.
• W2155873662 cites W2029145065 @default.
• W2155873662 cites W2030311010 @default.
• W2155873662 cites W2049554771 @default.
• W2155873662 cites W2049796688 @default.
• W2155873662 cites W2096532988 @default.
• W2155873662 cites W2113322194 @default.
• W2155873662 cites W2128219379 @default.
• W2155873662 cites W2134855422 @default.
• W2155873662 cites W2137069992 @default.
• W2155873662 cites W2140480989 @default.
• W2155873662 cites W2148513135 @default.
• W2155873662 cites W2158506982 @default.
• W2155873662 cites W2159883745 @default.
• W2155873662 cites W2172193326 @default.
• W2155873662 doi "https://doi.org/10.2337/dc14-2365" @default.
• W2155873662 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25633662" @default.
• W2155873662 hasPublicationYear "2015" @default.
• W2155873662 type Work @default.
• W2155873662 sameAs 2155873662 @default.
• W2155873662 citedByCount "156" @default.
• W2155873662 countsByYear W21558736622015 @default.
• W2155873662 countsByYear W21558736622016 @default.
• W2155873662 countsByYear W21558736622017 @default.
• W2155873662 countsByYear W21558736622018 @default.
• W2155873662 countsByYear W21558736622019 @default.
• W2155873662 countsByYear W21558736622020 @default.
• W2155873662 countsByYear W21558736622021 @default.
• W2155873662 countsByYear W21558736622022 @default.
• W2155873662 countsByYear W21558736622023 @default.
• W2155873662 crossrefType "journal-article" @default.
• W2155873662 hasAuthorship W2155873662A5000118493 @default.
• W2155873662 hasAuthorship W2155873662A5012223927 @default.
• W2155873662 hasAuthorship W2155873662A5039965133 @default.
• W2155873662 hasAuthorship W2155873662A5043462775 @default.
• W2155873662 hasAuthorship W2155873662A5072715177 @default.
• W2155873662 hasAuthorship W2155873662A5073917506 @default.
• W2155873662 hasAuthorship W2155873662A5085478829 @default.
• W2155873662 hasBestOaLocation W21558736621 @default.
• W2155873662 hasConcept C126322002 @default.
• W2155873662 hasConcept C126894567 @default.
• W2155873662 hasConcept C134018914 @default.
• W2155873662 hasConcept C2775887513 @default.
• W2155873662 hasConcept C2777180221 @default.
• W2155873662 hasConcept C2780031085 @default.
• W2155873662 hasConcept C555293320 @default.
• W2155873662 hasConcept C71924100 @default.
• W2155873662 hasConceptScore W2155873662C126322002 @default.
• W2155873662 hasConceptScore W2155873662C126894567 @default.
• W2155873662 hasConceptScore W2155873662C134018914 @default.
• W2155873662 hasConceptScore W2155873662C2775887513 @default.
• W2155873662 hasConceptScore W2155873662C2777180221 @default.
• W2155873662 hasConceptScore W2155873662C2780031085 @default.
• W2155873662 hasConceptScore W2155873662C555293320 @default.
• W2155873662 hasConceptScore W2155873662C71924100 @default.
• W2155873662 hasFunder F4320306257 @default.
• W2155873662 hasIssue "3" @default.
• W2155873662 hasLocation W21558736621 @default.
• W2155873662 hasLocation W21558736622 @default.
• W2155873662 hasOpenAccess W2155873662 @default.
• W2155873662 hasPrimaryLocation W21558736621 @default.
• W2155873662 hasRelatedWork W2134652590 @default.
• W2155873662 hasRelatedWork W2137986270 @default.
• W2155873662 hasRelatedWork W2148119499 @default.
• W2155873662 hasRelatedWork W2173615285 @default.
• W2155873662 hasRelatedWork W2314880155 @default.
• W2155873662 hasRelatedWork W2330830805 @default.
• W2155873662 hasRelatedWork W2406886656 @default.
• W2155873662 hasRelatedWork W2532067257 @default.
• W2155873662 hasRelatedWork W2758610685 @default.
• W2155873662 hasRelatedWork W3021151089 @default.
• W2155873662 hasVolume "38" @default.
• W2155873662 isParatext "false" @default.
• W2155873662 isRetracted "false" @default.
• W2155873662 magId "2155873662" @default.
• W2155873662 workType "article" @default.